<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336">
  <stage>Registered</stage>
  <submitdate>30/08/2005</submitdate>
  <approvaldate>9/09/2005</approvaldate>
  <actrnumber>ACTRN12605000345684</actrnumber>
  <trial_identification>
    <studytitle>Breast milk and Iodine Study</studytitle>
    <scientifictitle>A randomised double-blind, placebo-controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast-fed infants</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known
</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Iodine status</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Breast feeding</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Random allocation of placebo, iodine (75 micrograms/day), or iodine (150 micrograms/day) supplements to lactating women for the first six months of lactation.</interventions>
    <comparator>Placebo</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Breast-milk iodine concentration</outcome>
      <timepoint>At 1, 2, 4, 8, 12, 16, 20 and 24 weeks post-partum</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Iodine status of mothers and babies.</outcome>
      <timepoint>After six months of maternal supplementation.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Commitment to six months of breast-feeding.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No known thyroid disease. Not taking iodine containing dietary supplements. Singleton birth. Premature (&lt;38 weeks) birth.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Randomised, double-blind allocation placebo and iodine supplements (75 micrograms 150 microgram) in coded containers</concealment>
    <sequence>The random allocation sequence was generated by Microsoft Excel. The restriction method was a randomised block.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/05/2004</anticipatedstartdate>
    <actualstartdate>1/05/2004</actualstartdate>
    <anticipatedenddate />
    <actualenddate>31/10/2005</actualenddate>
    <samplesize>120</samplesize>
    <actualsamplesize>106</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Dunedin, Otago</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Otago, Dunedin, New Zealand</primarysponsorname>
    <primarysponsoraddress>Department of Human Nutrition
University of Otago
Dunedin, New Zealand 
9054</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Otago University Research Grant</fundingname>
      <fundingaddress>Division of Sciences
University of Otago
Dunedin, New Zealand 
9054</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Laurenson's Fund</fundingname>
      <fundingaddress>Otago Medical Research Foundation
PO Box 5077
Dunedin, New Zealand
9058
</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>New Zealand has low soil iodine and the NZ diet can be low in iodine. Breastfeeding women need to get enough iodine in their diet so that they make milk with sufficient levels of iodine. This study will measure the amount of iodine in breastmilk in women who are taking a placebo (i.e. Is there enough iodine in the diet of breastfeeding NZ women now?) or iodine containing supplement (i.e. If not, will more iodine in the diet make the iodine levels in their breastmilk increase?).</summary>
    <trialwebsite />
    <publication>Mulrine HM, Skeaff SA, Ferguson EL, Gray AM, Valeix P. Breast milk iodine concentration declines over the first six months postpartum in iodine-deficient women. American Journal of Clinical Nutrition 92;849-56 (2010)</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Otago Ethics Committee</ethicname>
      <ethicaddress>University of Otago
Dunedin, New Zealand
9054</ethicaddress>
      <ethicapprovaldate>16/03/2004</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Dr Sheila  Skeaff</name>
      <address>Department of Human Nutrition
University of Otago
PO Box 56
Dunedin 9001</address>
      <phone>+64 3 4797944</phone>
      <fax>+64 3 4797958</fax>
      <email>sheila.skeaff@stonebow.otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Dr Sheila  Skeaff</name>
      <address>Department of Human Nutrition
University of Otago
PO Box 56
Dunedin 9001</address>
      <phone>+64 3 4797944</phone>
      <fax>+64 3 4797958</fax>
      <email>sheila.skeaff@stonebow.otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Sheila Skeaff</name>
      <address>Dept Human Nutrition
University of Otago
Dunedin, New Zealand
9054</address>
      <phone>+643 479 7944</phone>
      <fax />
      <email>sheila.skeaff@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>